Prevalence of Lyme Disease in the US Is 10-Times Higher Than Previously Reported
The article contains solid background information and also includes helpful testing and treatment tips. I think the most important part comes at the end, where he quotes Lyme disease expert Richard Horowitz, MD, author of the new book, Why Can’t I Get Better? Solving the Mystery of Lyme and Chronic Disease:
“This condition is better termed Lyme MSIDS, short for Multiple Systemic Infectious Disease Syndrome. MSIDS is like Pandora’s Box because it includes many infections, co-infections and secondary infections. Treatment should be tailored to each patient individually.”
I think this statement embodies the future of proper diagnosis and treatment. The label of Lyme Disease is inappropriate for what we’re actually experiencing. On one hand, the criteria for diagnosis of Lyme Disease is set too narrowly by organizations such as the CDC. Then again, the term Lyme Disease has become a catch-all for inflammatory diseases caused by unknown pathogenic organisms. We don’t always know which pathogens are the culprits. Thus, we have a paradox, that patients are both underdiagnosed and overdiagnosed because of inadequate testing methods. This is the true crux of the dilemma that Lyme patients face. And of course there is the larger dilemma of lack of access to healthcare in the US. But that’s a topic for another day.